Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PER, SCZ

Neil L. Pruitt Jr., Chairman and CEO of PruittHealth, Appointed to Coronavirus Commission for Safety and Quality in Nursing Homes


NORCROSS, Ga., June 19, 2020 /PRNewswire/ -- One of 25 experts selected nationwide, Neil L. Pruitt Jr., chairman and CEO of PruittHealth, has been appointed to serve on a new, independent commission set to begin a comprehensive assessment of the nursing home response to the COVID-19 pandemic.

"It is an honor and a privilege to be selected as a member of this commission and advocate for one of the most vulnerable patient populations our company proudly has served for 50 years," Pruitt said. "For me, this commission is an extension of our Commitment to Caring, and I look forward to sharing with fellow members the valuable experiences and lessons learned as our country grapples with COVID-19." 

The commission's work will inform efforts to safeguard the health and quality of life of vulnerable Americans, as well as prepare for future threats to nursing home residents' safety and to public health. 

Specifically, the commission is tasked to: 

The Centers for Medicare & Medicaid Services (CMS) announced the formation of the Coronavirus Commission for Safety and Quality in Nursing Homes on May 14. MITRE, an independent, not-for-profit organization, is standing up the commission and facilitating its activities and will independently author and deliver a report on the commission's findings and recommendations to CMS on September 1.

Learn more about the Coronavirus Commission for Safety and Quality in Nursing Homes at https://sites.mitre.org/nhcovidcomm/.

About PruittHealth
A family-owned organization for 50 years, PruittHealth provides a seamless network of post-acute care services and resources, offering skilled nursing care, home health care, end-of-life hospice care, therapy services, as well as pharmacy and infusion services across the Southeast. Our 16,000 employed partners serve approximately 24,000 patients daily in more than 180 locations in Florida, Georgia, North Carolina, and South Carolina. For more information about our commitment to caring, visit pruitthealth.com.

SOURCE PruittHealth


These press releases may also interest you

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

at 17:31
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

at 17:31
DelveInsight's Corneal Implant Market...



News published on and distributed by: